|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM187011060 |
003 |
DE-627 |
005 |
20250210061727.0 |
007 |
tu |
008 |
231223s2009 xx ||||| 00| ||chi c |
028 |
5 |
2 |
|a pubmed25n0623.xml
|
035 |
|
|
|a (DE-627)NLM187011060
|
035 |
|
|
|a (NLM)19278588
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a chi
|
100 |
1 |
|
|a Fang, Wei
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Effect of C5a on expression of thrombomodulin in endothelial cells in vitro
|
264 |
|
1 |
|c 2009
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 11.05.2010
|
500 |
|
|
|a Date Revised 12.03.2009
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a OBJECTIVE: To investigate the effect of C5a on the expression of thrombomodulin (TM) in human umbilical vein endothelial cells (HUVECs)
|
520 |
|
|
|a METHODS: HUVECs cultured in vitro were stimulated with C5a for 8, 12, 16, 20 hours in a concentration of 200 microg/L, and also with different concentrations of 100, 200, 300 microg/L for 12 hours respectively. The levels of both mRNA and protein expression of TM was detected by real-time polymerase chain reaction (PCR) and Western blotting respectively, and the dose and time dependent effects of C5a on the expression of TM were evaluated
|
520 |
|
|
|a RESULTS: C5a down-regulated the TM expression at both protein and mRNA level. The down-regulation was time-dependent [(93.11+/- 1.57) x10(-2) , (71.05+/-3.39)x10(-2), (65.48+/-4.28)x10(-2), (62.69+/-4.03)x10(-2)at protein level and (301.71+/-80.40)x10(-6), (38.29+/-20.24)x10(-6), (8.82+/-2.66)x10(-6), (7.05+/-0.80)x10(-6) at mRNA level, all P<0.05] and dose-dependent [(113.25+/-3.97)x10(-2), (80.18+/-2.56)x10(-2), (73.22+/- 4.36)x10(-2) at protein level and (401.77+/-20.46)x10(-6), (31.12+/-3.51)x10(-6), (18.19+/-1.46)x10(-6) at mRNA level , all P<0.05]. When concentration of C5a at 300 microg/L was used to stimulate HUVECs for longer than 12 hours, the lowering of TM at protein level was slowed down obviously. And concentration of C5a at 200 microg/L was used to stimulate HUVECs for 12 hours, the lowering of TM at mRNA level was slowed down obviously
|
520 |
|
|
|a CONCLUSION: C5a can depress the gene expression of TM, and then affect the protein's translation. By this means, C5a can lead to hypercoagulability and inflammatory injuries in sepsis
|
650 |
|
4 |
|a English Abstract
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a RNA, Messenger
|2 NLM
|
650 |
|
7 |
|a Thrombomodulin
|2 NLM
|
650 |
|
7 |
|a Complement C5a
|2 NLM
|
650 |
|
7 |
|a 80295-54-1
|2 NLM
|
700 |
1 |
|
|a Guo, Zhen-hui
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Bao-quan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wu, Xiao-feng
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Ping
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lv, Feng-lin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Su, Lei
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
|d 1998
|g 21(2009), 3 vom: 12. März, Seite 168-71
|w (DE-627)NLM098227793
|x 1003-0603
|7 nnns
|
773 |
1 |
8 |
|g volume:21
|g year:2009
|g number:3
|g day:12
|g month:03
|g pages:168-71
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 21
|j 2009
|e 3
|b 12
|c 03
|h 168-71
|